News and Comments

AGEN: IRRATIONAL REACTION AGAINST EXPECTED NEWS

  Thursday, March 20, 2014
 More...

PROSENSA: BACK INTO THE LIMELIGHT

  Tuesday, March 18, 2014

Prosensa Holding N.V. (RNA) might have good news that was made possible through insightful observation following past results that almost condemned the Dutch biopharmaceutical company’s compound drisapersen for the treatment of Duchenne Muscular Dystrophy (DMD).  More...

JAKAFI DEVELOPED BY INCYTE MET THE PRIMARY ENDPOINTS FOR POLYCYTHEMIA VERA

  Friday, March 07, 2014

Incyte (INCY) announced results from pivotal Phase 3 trial of Jakafi (ruxolitinib) in polycythemia vera patients who are resistant to or intolerant of hydroxyurea. The results met the primary endpoints; achieving phlebotomy independence and reducing spleen size by 35 percent or more compared to best available therapy.  More...


Recent Postings


Archive


Tags

Vertex (VRTX) Human Genome Sciences (HGSI) Exelixis (EXEL) ISIS (ISIS) Abbott Laboratories (ABT) Pluristem (PSTI) Biocryst (BCRX) Human Longevity (HLI) PTC Therapeutics (PTCT) AERIE PHARMACEUTICALS Spike Therapeutics (ONCE) Cytokinetics (CYTK) Intercept (ICPT) Dynavax (DVAX) GlaxoSmithKline (GSK) Tysabri KERYX (KERX) Illumina (ILMN) Array Pharmaceuticals (ARRY) KITE (KITE) ADVENTRIX (ANX) Endometrial Cancer Idenix (IDIX) Sequenom (SQNM) ZALTRAP™ Auspex (ASPX) Galena (GALE) Inovio (INO) Xoma (XOMA) Incyte (INCY) INNOVIVA (INVA) JUNO (JUNO) NANTKWEST (NK) Regeneron (REGN) SUNESIS PHARMACEUTICALS (SNSS) Trastuzumab-DM1 Sanofi-Aventis (SAN) Vitae Pharmaceuticals (VTAE) Global Cell Therapeutics (GBT) Agenus (AGEN Zerenex Roche (ROCHE) Editas (EDIT) Prosensa (RNA) Sanofi (SNY) Ionis (IONS) Dendreon (DNDN) Anadys (ANDS) Intermune (ITMN) GUARDIAN HEALTH Theravance Bio Pharma (TBPH) RenenxBio (RGNX) Herceptin Gilead (GILD) Roche (RHHBY) Theravance (THRX) Telaprevir Micromet (MITI) Ridaforolimus Anacor (ANAC) Alnylam (ALNY) ACADIA (ACAD) Genentech Multiple Myeloma galapagos (GLPG) Alder Biopharmaceuticals (ALDR) Sanofi (SNA) Agenus (AGEN) Valeant Pharmaceuticals International (VRX) IDERA (IDRA) NEKTAR (NKTR)) Bristol-Myers Squibb (BMY) AGOS (ARGS) Onyx (ONXX) Prolor Biotech (PBTH) BIOMARIN (BMRN) OSI (OSIP) SERES THERAPEUTICS (MCRB) Sarepta (SRPT) Amgen (AMGN) HALOZYME (HALO) Merck (MRK) Elan (ELN) Benlysta (belimumab) Biogen Idec (BIIB) Velcade (bortezomib) CompuGen (CGEN) SYNTA (SNTA) Ziofpharm (ZIOP) TOKAI (TKAOI) Ariad (ARIA) Mirati Therapeutics (MRTX) ABBVIE (ABBV) Seattle Genetics (SGEN) Intrexon (XON) Sangamo (SGMO) Aimmune Therapeutics (AIMT) Rapamune Jazz Pharmaceuticals (JAZZ) Revlimid (lenolidamide) ImmunoGen (IMGN) VANDA (VNDA) REGULUS (RGLS) ARGOS (ARGS) ARCA (ABIO) C4 Therapeutics